A marijuana derivative called cannabidiol, or CBD, has begun making its way into supplements and even into foods, a use that runs afoul of an FDA designation of the compound as a prescription drug. A Harvard Medical School associate professor says CBD’s tangled legal status may provide an opportunity not only to clear up its status, but to bring clarity to the entire supplements industry.
Alvin Powell
• harvard
Aug. 2, 2019
•
~12 min
Propelled by her viral short story, Harvard alumna Kristen Roupenian publishes her first collection, visits Cambridge.
Jill Radsken
• harvard
Feb. 25, 2019
•
~7 min
MIT.nano building, the largest of its kind, will usher in a new age of nanoscale advancements.
David L. Chandler | MIT News Office
• mit
Sept. 23, 2018
•
~10 min
Historic building would create “design hub” for MIT, with benefits for surrounding community.
Peter Dizikes | MIT News Office
• mit
June 14, 2018
•
~8 min
Jaramillo lab launches a summer program to broaden the horizons of local students interested in materials science and engineering.
Denis Paiste | Materials Research Laboratory
• mit
May 31, 2018
•
~6 min
At annual event, Boston Globe’s Spotlight team discusses its latest investigation into racism in Boston.
Rob Matheson | MIT News Office
• mit
March 30, 2018
•
~9 min